Ocular Therapeutix (OCUL) Shares Issued (2013 - 2026)

Ocular Therapeutix's Shares Issued history runs 14 years deep, the most recent figure standing at $294000.0 for Q1 2026.

• In Q1 2026, Shares Issued fell 92.97% year-over-year to $294000.0; the TTM figure through Mar 2026 stood at $710.3 million (up 328.29% YoY), while the FY2025 annual figure was $539.6 million, up 53008.76% from the prior year.
• Shares Issued was $294000.0 for Q1 2026 at Ocular Therapeutix, down from $522.0 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $522.0 million in Q4 2025 to a low of -$309.8 million in Q2 2024.
• Historically, Shares Issued has averaged $45.4 million across 5 years, with a median of $438500.0 in 2022.
• Biggest YoY gain for Shares Issued was 405480.77% in 2024; the steepest drop was 3610.64% in 2024.
• A 5-year view of Shares Issued shows it stood at $32000.0 in 2022, then tumbled by 75.0% to $8000.0 in 2023, then soared by 6450.0% to $524000.0 in 2024, then jumped by 99514.12% to $522.0 million in 2025, then slumped by 99.94% to $294000.0 in 2026.
• The last three Shares Issued figures came in at $294000.0 (Q1 2026), $522.0 million (Q4 2025), and $94.0 million (Q3 2025), per Business Quant data.